Disorders of glyoxylate metabolism (Q40061): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Linked ICD 10 | |||
| Property / Linked ICD 10: E74.9 / rank | |||
Normal rank | |||
Latest revision as of 05:43, 13 August 2026
Primary hyperoxaluria, or oxalosis, is a rare metabolic disorder transmitted as an autosomal recessive disease, including both type 1, the most frequent, and type 2, extremely rare. Hyperoxaluria type 1 is due to a defect of the peroxysomal hepatic enzyme L-alanine: glyoxylate aminotransferase (AGT). Hyperoxaluria type 2 is extremely rare and is due to glycerate dehydrogenase deficiency.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 5C51.2 |
||
| English | Disorders of glyoxylate metabolism |
Primary hyperoxaluria, or oxalosis, is a rare metabolic disorder transmitted as an autosomal recessive disease, including both type 1, the most frequent, and type 2, extremely rare. Hyperoxaluria type 1 is due to a defect of the peroxysomal hepatic enzyme L-alanine: glyoxylate aminotransferase (AGT). Hyperoxaluria type 2 is extremely rare and is due to glycerate dehydrogenase deficiency. |
Statements
CID11:5C51.2
0 references
dki-india-5C51.2
0 references
Concluído
0 references
13 August 2026
0 references
